Study Watch with Irregular Pulse Monitor (Home) vs Cardiomo
AI Verdict
Choose Study Watch with Irregular Pulse Monitor (Home) if…
Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if you are a clinical researcher or healthcare provider focused on large-scale observational studies and the collection of rich, complex physiological datasets. This prescription-only wearable is designed for unobtrusive, continuous monitoring of various biosignals, including ECG and irregular pulse for AFib detection, and has been utilized in studies for Parkinson's disease, heart failure, and mental health. Its robust data encryption and cloud-based analytics with machine learning are ideal for generating evidence and developing digital biomarkers in diverse populations.
View Study Watch with Irregular Pulse Monitor (Home) →Choose Cardiomo if…
Choose Cardiomo if you require a medical-grade wearable patch for continuous and remote heart health monitoring with real-time alerts for patients and caregivers. This tool is particularly well-suited for detecting cardiovascular diseases like arrhythmias and potential heart attacks, and for monitoring vital signs such as ECG, heart rate, respiration, and skin temperature. Its mobile application and notification system, including fall detection, make it a strong choice for remote patient monitoring, especially for older individuals or those needing consistent oversight outside of a hospital setting.
View Cardiomo →When considering AI-powered wearable devices for cardiac monitoring, physicians have options like the Verily Study Watch with Irregular Pulse Monitor (Home) and Cardiomo. The Verily Study Watch is primarily designed for clinical research and prescription use, focusing on unobtrusive collection of physiological data, including on-demand single-channel ECG and irregular pulse monitoring for AFib detection. Its strength lies in its advanced sensors and cloud-based analytics for detailed data capture in a research or prescribed setting. Cardiomo, on the other hand, emphasizes continuous, real-time remote heart health monitoring with a medical-grade wearable patch, offering AI-powered disease detection for various cardiovascular events and immediate alerts to users and caregivers. Cardiomo’s feature set, including fall detection and a mobile application, suggests a broader application for ongoing patient management and proactive intervention.
The key practical difference lies in their primary use cases and deployment. Verily’s Study Watch is a prescription-only device geared towards clinical research and specific healthcare use, implying a more controlled and potentially data-intensive environment. Its focus on detailed physiological and environmental data collection makes it suitable for physicians involved in studies or requiring comprehensive data for specific diagnostic purposes. Cardiomo, with its continuous monitoring, real-time alerts, and mobile app integration, appears more suited for ongoing remote patient monitoring, particularly for those at risk of cardiovascular events or in geriatric care where immediate alerts and caregiver involvement are crucial. Physicians prioritizing in-depth data for research or specific diagnostic needs might lean towards Verily, while those seeking a more comprehensive, real-time monitoring solution for patient management and timely intervention may find Cardiomo more aligned with their practice.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Study Watch with Irregular Pulse Monitor (Home) | Cardiomo |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Wearable device with cloud-based data processing. | Cloud-based with wearable device and mobile app |
| FDA Status | 1 AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardiomoCardiomo is designed for continuous and remote monitoring with a user-friendly mobile application for patients and caregivers, offering real-time alerts and health insights. In contrast, the Verily Study Watch is primarily a prescription-only device for clinical research, with participants only able to view the time and date, suggesting a less direct user experience for patients.
Clinical Value
Study Watch with Irregular Pulse Monitor (Home)Both tools offer medical-grade data collection and AI-powered analysis for cardiovascular health. However, Verily Study Watch has received FDA 510(k) clearance for its irregular pulse monitor feature for AFib detection and has been extensively used in various clinical research studies, including those for Parkinson's disease and heart failure. Cardiomo is CE-MDR certified and has undergone clinical validation against gold-standard references for various vital parameters.
Pricing & Value
TieBoth companies state that pricing information is not publicly available and requires direct contact. While Cardiomo previously offered a consumer price, its current pricing is not transparent. Therefore, it is difficult to determine a winner in this dimension without more information.
Enterprise Readiness
CardiomoCardiomo explicitly states HIPAA compliance and offers a cloud-based analytics system for healthcare providers and relatives, indicating a readiness for broader deployment in healthcare settings. Verily states its services may be subject to HIPAA, but has faced a lawsuit alleging HIPAA breaches, which could raise concerns for enterprise adoption.
Innovation
Study Watch with Irregular Pulse Monitor (Home)Verily Study Watch focuses on collecting rich and complex datasets for clinical and observational studies, with advanced physiological and environmental sensors and cloud-based machine learning. Its ongoing research in areas like digital biomarkers for walking behavior and sleep, and collaborations with entities like Samsung for integrated solutions, demonstrate a strong commitment to innovation in precision health. Cardiomo also uses AI-powered disease detection and real-time alerts, but Verily's emphasis on research and broader data collection for novel insights gives it an edge.
Support & Docs
TieNeither the provided structured facts nor web searches offer specific details about the level of customer support or publicly available documentation for either product. Therefore, it is not possible to determine a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Study Watch with Irregular Pulse Monitor (Home) | Cardiomo |
|---|---|---|
| Name | Study Watch with Irregular Pulse Monitor (Home) | Cardiomo |
| Company | Verily Life Sciences LLC | Cardiomo, Inc. |
| Description | The Verily Study Watch with Irregular Pulse Monitor (Home) is a prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics. | Cardiomo offers a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Key Features (Monitoring) | On-demand single-channel ECG measurement, Irregular pulse monitoring for atrial fibrillation (AFib) detection, Multiple physiological sensors (heart rate, electrodermal activity, inertial movements), Environmental sensors | Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Fall detection |
| Battery Life | Up to one week | Up to 7-10 days |
Videos
Demos, reviews, and walkthroughs featuring Study Watch with Irregular Pulse Monitor (Home) and Cardiomo.